Biochemical Mapping Helps Explain Who Will Respond to Antidepressants

Published July 22, 2013

Biochemical Mapping Helps Explain Who Will Respond to Antidepressants
These changes occur in a neurotransmitter pathway that is connected to the pineal gland, the part of the endocrine system that controls the sleep cycle, suggesting an added link between sleep, depression and treatment outcomes. The study, published on … Read more on Fars News Agency

Integrating data to see the full benefits picture
Consider the following case of a plan sponsor that has an average prevalence of depression within the plan in Canada: one out of seven claimants within the prescription drug plan benefit is actively treating depression. This figure does not consider … Read more on Benefits Canada